Chiba K, Ishizaki T, Tabuchi T, Wagatsuma T, Nakazawa Y
Obstet Gynecol. 1982 Nov;60(5):620-6.
The authors studied antipyrine disposition before and after delivery in 4 epileptic women whose anticonvulsant plasma level per dosage ratio was lowered during pregnancy, and compared the results to those found in nonpregnant women undergoing antiepileptic treatment (N = 6) and healthy women (N = 6). The antipyrine clearance at term (0.53 +/- 0.11 ml/min/kg, mean +/- SD) was lower than it was early during puerperium (0.70 +/- 0.14 ml/min/kg, P less than .05) and approximately 3 months after delivery (1.14 +/- 0.26 ml/min/kg, P less than .01). The antipyrine clearance in nonpregnant epileptics (1.17 +/- 0.44 ml/min/kg) was comparable to that found 3 months after delivery, whereas it was significantly (P less than .01) higher than that found in healthy women (0.47 +/- 0.02 ml/min/kg). These observations suggest that the fall during pregnancy of anticonvulsant plasma concentrations relative to dosage is not attributable to the enhanced oxidative process of hepatic drug metabolism.
作者研究了4名癫痫女性分娩前后安替比林的处置情况,这些女性在孕期抗惊厥药血浆水平与剂量之比降低,并且将结果与接受抗癫痫治疗的非孕女性(N = 6)和健康女性(N = 6)的结果进行了比较。足月时安替比林清除率(0.53±0.11毫升/分钟/千克,均值±标准差)低于产褥期早期(0.70±0.14毫升/分钟/千克,P<0.05)以及分娩后约3个月(1.14±0.26毫升/分钟/千克,P<0.01)。非孕癫痫患者的安替比林清除率(1.17±0.44毫升/分钟/千克)与分娩后3个月时相当,然而显著高于健康女性(0.47±0.02毫升/分钟/千克,P<0.01)。这些观察结果表明,孕期抗惊厥药血浆浓度相对于剂量的下降并非归因于肝脏药物代谢氧化过程增强。